Roche Can't Ax Ravgen's DNA Tech Patent Suit, Judge Finds
Swiss pharmaceutical giant Roche's subsidiaries shouldn't be able to escape a patent lawsuit brought by Ravgen Inc. over DNA technology, a Delaware magistrate judge said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article